ADRB2 and Stridor: In concert with the beneficial effects of GCs in αAR-signaling, the use of nonselective αAR agonists with βAR activity for the treatment of stridor (i.e., epinephrine) may lead to enhanced GC signaling via β2-AR-induced upregulation of GRE-dependent transcription [81].